CLINICAL_TRIALS
trial_result
· 2009-09-02
Clinical Trial Update: Rebif New Formulation (RNF) Quality of Life (QOL) Study [Phase 3]
Summary
Phase 3 study evaluating Rebif New Formulation (RNF) for quality of life in relapsing multiple sclerosis; completed with results posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Relapsing Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2009-09-02